Paediatric rheumatology: A disease activity index for juvenile SpA-a welcome addition

Roberta A Berard1, Ronald M Laxer2

  • 1Section of Rheumatology, Children's Hospital, London Health Sciences Centre, Department of Paediatrics, Western University, 800 Commissioners Road East, London, ON N6A 5W9, Canada.

Nature Reviews. Rheumatology
|September 10, 2014
PubMed

Insights

A new juvenile spondyloarthritis (SpA) disease activity index may bridge the gap in classification criteria. This tool aims to comprehensively assess disease severity and progression in pediatric patients.

Area of Science:

  • Pediatric rheumatology
  • Clinical assessment tools
  • Disease classification

Background:

  • Juvenile spondyloarthritis (SpA) lacks universally accepted classification criteria.
  • This absence hinders the development of disease severity and progression assessment tools.

Purpose of the Study:

  • To evaluate if a new juvenile SpA disease activity index addresses the need for standardized classification.
  • To determine if this index serves as a comprehensive clinical assessment tool.

Main Methods:

  • Development and validation of a novel juvenile SpA disease activity index.
  • Assessment of the index's comprehensiveness and clinical utility.

Main Results:

  • The new index provides a standardized approach to classifying juvenile SpA.
  • Preliminary data suggests the index is a comprehensive tool for clinical use.

Conclusions:

  • The newly developed juvenile SpA disease activity index shows promise in standardizing classification.
  • Further validation is needed to confirm its comprehensive utility in clinical practice.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
21
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
21
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
27